As for the 7c cap raise, it was originally offered to retail but they didn't want it, so later it was taken up by sophs at about half the amount.
No one wanted it when shares dropped from 7c to 5.4c after first CR, but suddenly everyone wanted it when it bounced back to 12c.
They needed the cashflow short term, and possibly even only took up half of previous offer at 7c because they were working on the deal with Hologic in the background.
Long term the company has value, but retail on asx seem more happy putting their money on speccy miners with a hole in the ground, rather than a company on a turnaround path with FDA approval, and now a transformational agreement with Hologic.
Barring any new agreements or sales, it might take a number of months to really gain traction, but I see better fundamentals here than most stocks on the asx.
LDX Price at posting:
7.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)